These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 18589184)

  • 1. Case report: successful treatment of posttransplant lymphoproliferative disorder and quiescence of dermatomyositis with rituximab and sirolimus.
    Kaposztas Z; Etheridge WB; Kahan BD
    Transplant Proc; 2008 Jun; 40(5):1744-6. PubMed ID: 18589184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab in association with rapamycin for post-transplant lymphoproliferative disease treatment.
    Garcia VD; Bonamigo Filho JL; Neumann J; Fogliatto L; Geiger AM; Garcia CD; Barros V; Keitel E; Bittar AE; Ferrera des Santos A; Roithmann S
    Transpl Int; 2003 Mar; 16(3):202-6. PubMed ID: 12664217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel treatment with rituximab of oropharyngeal posttransplant lymphoproliferative disorder after heart transplantation.
    Kaczmarek I; Beiras-Fernandez A; Sadoni S; Bengel D; Deutsch MA; Meiser B; Reichart B
    Exp Clin Transplant; 2005 Dec; 3(2):381-4. PubMed ID: 16417448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirolimus-induced remission of posttransplantation lymphoproliferative disorder.
    Cullis B; D'Souza R; McCullagh P; Harries S; Nicholls A; Lee R; Bingham C
    Am J Kidney Dis; 2006 May; 47(5):e67-72. PubMed ID: 16632009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid response to rituximab in a pediatric liver transplant recipient with post-transplant lymphoproliferative disease and maintenance with sirolimus monotherapy.
    Al-Akash SI; Al Makadma AS; Al Omari MG
    Pediatr Transplant; 2005 Apr; 9(2):249-53. PubMed ID: 15787802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low viral load post-transplant lymphoproliferative disease localized within the tongue.
    Henry DD; Hunger SP; Braylan RC; Dharnidharka VR
    Transpl Infect Dis; 2008 Dec; 10(6):426-30. PubMed ID: 18657087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term maintenance therapy for post-cardiac transplant monoclonal lymphoproliferative disorder: caveat mammalian target of rapamycin.
    Khalpey Z; Miller DV; Schmitto JD; Kushwaha SS
    Transplant Proc; 2011 Jun; 43(5):1893-9. PubMed ID: 21693296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer effect of sirolimus in renal allograft recipients with de novo malignancies.
    Boratyńska M; Watorek E; Smolska D; Patrzałek D; Klinger M
    Transplant Proc; 2007 Nov; 39(9):2736-9. PubMed ID: 18021973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab and rapamycin for posttransplant lymphoproliferative disease treatment: report of three cases.
    Garcia VD; Bonamigo-Filho JS; Neumann J; Fogliatto L; Gaiger AM; Garcia CD; Barros V; Keitel E; Bittar AE; Santos AF; Roithmann S
    Transplant Proc; 2002 Nov; 34(7):2993-5. PubMed ID: 12431680
    [No Abstract]   [Full Text] [Related]  

  • 10. Post-transplant lymphoproliferative disorder--the potential of proliferation signal inhibitors.
    Pascual J
    Nephrol Dial Transplant; 2007 May; 22 Suppl 1():i27-35. PubMed ID: 17456616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirolimus in pediatric liver transplantation: a single-center experience.
    Gibelli NE; Tannuri U; Pinho-Apezzato ML; Tannuri AC; Maksoud-Filho JG; Andrade WC; Velhote MC; Santos MM; Ayoub AA; Marques da Silva M
    Transplant Proc; 2009 Apr; 41(3):901-3. PubMed ID: 19376384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-transplant lymphoproliferative disorders after lung transplantation: first-line treatment with rituximab may induce complete remission.
    Knoop C; Kentos A; Remmelink M; Garbar C; Goldman S; Feremans W; Estenne M
    Clin Transplant; 2006; 20(2):179-87. PubMed ID: 16640524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosa-associated lymphoid tissue gastric lymphoma regression in a renal transplant patient after conversion of the immunosuppression to sirolimus: a case report.
    Lasmar EP; Coelho LG; Lasmar MF; Lasmar LF; Lima PV; Nogueira AF
    Transplant Proc; 2009 Apr; 41(3):959-61. PubMed ID: 19376398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of intraocular post-transplant lymphoproliferative disorder with intravenous rituximab.
    Iu LP; Yeung JC; Loong F; Chiang AK
    Pediatr Blood Cancer; 2015 Jan; 62(1):169-72. PubMed ID: 25174958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttransplant lymphoproliferative disorder in the wall of a lymphocele: a case report.
    Basic-Jukic N; Kes P; Coric M; Kastelan Z; Pasini J; Bubic-Filipi L
    Transplant Proc; 2009 Jun; 41(5):1966-8. PubMed ID: 19545769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Post transplant lymphoproliferative disorder (PTLD)--10 years follow-up].
    Ignacak E; Betkowska-Prokop A; Kuźniewski M; Rudzki Z; Okoń K; Skotnicki A; Jurczak W; Kulig J; Czupryna A; Bucki J; Sułowicz W
    Przegl Lek; 2011; 68(12):1202-3. PubMed ID: 22519281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of chemotherapy and rituximab for treatment of posttransplant lymphoproliferative disorder in solid organ transplantation.
    Lee JJ; Lam MS; Rosenberg A
    Ann Pharmacother; 2007 Oct; 41(10):1648-59. PubMed ID: 17848421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posttransplant lymphoproliferative disease: a series of 23 cases.
    Martín-Gómez MA; Peña M; Cabello M; Burgos D; Gutierrez C; Sola E; Acedo C; Bailén A; Gonzalez-Molina M
    Transplant Proc; 2006 Oct; 38(8):2448-50. PubMed ID: 17097963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cancer after kidney transplantation].
    Sandrini S; Setti G; Bossini N; Maiorca P
    G Ital Nefrol; 2004; 21 Suppl 26():S67-73. PubMed ID: 15732048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posttransplant lymphoproliferative disorder with lung involvement in a renal transplant recipient.
    Mirza EI; Mutluay R; Suyani E; Okyay GU; Akyurek N; Aki SZ; Derici U; Arinsoy T
    Exp Clin Transplant; 2011 Dec; 9(6):425-8. PubMed ID: 22142053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.